We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+17.61%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$10.6B
AUM Growth
+$1.44B
Cap. Flow
+$92.7M
Cap. Flow %
0.88%
Top 10 Hldgs %
22.72%
Holding
2,357
New
64
Increased
127
Reduced
1,296
Closed
88

Sector Composition

Rank Sector Weight
1 Technology 20.97%
2 Healthcare 12.78%
3 Financials 12.6%
4 Consumer Discretionary 11.75%
5 Industrials 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYTK icon
1401
Cytokinetics
CYTK
$10.2B
$591K 0.01%
28,455
LNN icon
1402
Lindsay Corp
LNN
$1.17B
$590K 0.01%
4,595
SYKE
1403
DELISTED
SYKES Enterprises Inc
SYKE
$590K 0.01%
15,654
MEI icon
1404
Methode Electronics
MEI
$593M
$588K 0.01%
15,351
INO icon
1405
Inovio Pharmaceuticals
INO
$93M
$587K 0.01%
5,527
TNC icon
1406
Tennant Co
TNC
$1.15B
$587K 0.01%
8,362
PFS icon
1407
Provident Financial Services
PFS
$3.26B
$586K 0.01%
32,624
OCUL icon
1408
Ocular Therapeutix
OCUL
$2.22B
$585K 0.01%
28,266
+882
+3% +$13.1K
ASTE icon
1409
Astec Industries
ASTE
$975M
$585K 0.01%
10,105
ATRA icon
1410
Atara Biotherapeutics
ATRA
$76.7M
$584K 0.01%
1,190
HOUS
1411
DELISTED
Anywhere Real Estate
HOUS
$582K 0.01%
44,378
-8,984
-17% -$107K
TTGT icon
1412
TechTarget
TTGT
$277M
$580K 0.01%
9,817
JOE icon
1413
St. Joe Company
JOE
$3.89B
$580K 0.01%
13,663
MLAB icon
1414
Mesa Laboratories
MLAB
$633M
$579K 0.01%
2,020
CSGS
1415
DELISTED
CSG Systems International
CSGS
$579K 0.01%
12,844
-2,261
-15% -$96.3K
ALLO icon
1416
Allogene Therapeutics
ALLO
$683M
$578K 0.01%
22,907
GWB
1417
DELISTED
Great Western Bancorp, Inc.
GWB
$578K 0.01%
27,651
ODP
1418
DELISTED
ODP
ODP
$578K 0.01%
19,714
-3,807
-16% -$96.2K
VCEL icon
1419
Vericel Corp
VCEL
$2.28B
$575K 0.01%
18,632
EIDX
1420
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$574K 0.01%
4,364
-1,212
-22% -$107K
SAFE
1421
DELISTED
Safehold Inc.
SAFE
$574K 0.01%
7,916
ALEX
1422
DELISTED
Alexander & Baldwin
ALEX
$573K 0.01%
33,353
MTRN icon
1423
Materion
MTRN
$5.88B
$571K 0.01%
8,965
RLAY icon
1424
Relay Therapeutics
RLAY
$4.37B
$571K 0.01%
13,730
ZUO
1425
DELISTED
Zuora, Inc.
ZUO
$568K 0.01%
40,773
-1,940
-5% -$22.1K

Similar funds

MetLife Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, MetLife Investment Management held 2,357 positions worth $10.6B, up 16% from $9.13B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

MetLife Investment Management's Q4 2020 filing shows 64 new, 127 increased, 1,296 reduced and 88 closed positions. Its largest new stake was Vanguard Short-Term Bond ETF: 4,766,514 shares worth $395M. The largest sale was Apple, an estimated $23.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q4 2020 buy was Vanguard Short-Term Bond ETF: 4,766,514 shares worth $395M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $23M increase.
  • MetLife Investment Management's biggest Q4 2020 reduction was Apple, cutting an estimated $23.3M.
  • MetLife Investment Management fully exited Dunkin' Brands Group, Inc. in Q4 2020, selling an estimated $3.86M.
  • MetLife Investment Management's ten largest holdings make up 23% of its $10.6B portfolio in Q4 2020.
  • MetLife Investment Management opened 64 new positions and closed 88 in Q4 2020.
  • MetLife Investment Management's portfolio value rose 16% quarter-over-quarter to $10.6B.

Based on MetLife Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.